Related Experiment Video
Updated: Nov 2, 2025

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children
Published on: September 11, 2018
Unintentional paediatric iron poisoning: A retrospective case series
Andrew K Crofton1,2, Keith Harris1,2,3, Carol Wylie3
1Department of Emergency Medicine, Clinical Toxicology Unit, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Insights
Unintentional iron poisoning in children is rare and typically mild. Focus on symptomatic children for assessment and treatment to avoid unnecessary interventions.
Area of Science:
- Pediatric Toxicology
- Environmental Health
- Public Health Measures
Background:
- Iron poisoning historically significant for child morbidity and mortality.
- Public health initiatives have reduced pediatric iron exposures.
- Need for a specific assessment approach for unintentional pediatric iron poisoning.
Purpose of the Study:
- Investigate unintentional iron poisoning in children.
- Develop a tailored assessment approach for this demographic.
- Evaluate predictors of toxicity in pediatric iron ingestions.
Main Methods:
- Retrospective observational study.
- Included children under 7 years old with unintentional iron poisoning.
- Data sourced from poison information services, toxicology units, and medical records (2015-2020).
Main Results:
- 54 children included; median age 2 years.
- 17% were symptomatic; no severe toxicity cases.
- Symptomatic children had significantly higher peak serum iron levels (66 μmol/L vs. 12 μmol/L).
Conclusions:
- Unintentional pediatric iron poisoning is uncommon and generally benign.
- Ingested dose is an unreliable predictor of toxicity.
- Focusing on symptomatic children optimizes assessment and management.
Objective:
Iron poisoning is a historically important cause of paediatric morbidity and mortality. In recent decades, public health measures have considerably reduced paediatric iron exposures. We investigated unintentional paediatric iron poisoning in children with the aim of developing an assessment approach specific for this group.
Methods:
This was a retrospective observational study of unintentional iron poisoning in children (<7 years old) referred to either a state-wide poisons information service or a tertiary clinical toxicology unit from 1 January 2015 to 16 February 2020. Patients were identified from prospective databases maintained by both services, and data were extracted from these in addition to the medical record.
Results:
There were 54 children included in the study (29 [54%] male; median age 2 years (range 8 months to 4 years). The median suspected dose of elemental iron ingested was 72 mg/kg (IQR 41-140 mg/kg). Seventeen (31%) children were symptomatic. There were no cases of severe toxicity. Children symptomatic with gastrointestinal toxicity had a median suspected dose ingested of 60 mg/kg (IQR 38-150 mg/kg) that was similar to asymptomatic children (81 mg/kg [IQR 41-143 mg/kg], P = 0.809). The median peak iron concentration was 49 μmol/L (IQR 13.5-67.5 μmol/L, range 4-75 μmol/L). Symptomatic children had a significantly higher median peak serum iron concentration of 66 μmol/L (IQR 54-68 μmol/L) compared to 12 μmol/L (IQR 9-15 μmol/L) in asymptomatic children (P < 0.001).
Conclusion:
Unintentional paediatric iron poisoning is uncommon and largely benign. Suspected dose ingested is a poor predictor of toxicity. Targeting investigations and interventions to symptomatic children should reduce unnecessary assessment and management while still safely managing the exposure.
More Related Videos
04:48Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
Published on: May 4, 2020
05:35Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Distribution